Skip to content

Understanding Staphylococcus lugdunensis Infections: A Genomic Analysis to Track Spread and Characteristics

The Study of Genome Characteristics and Molecular Epidemiology of Staphylococcus lugdunensis Based on Whole Genome Sequencing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129367
Enrollment
Unknown
Registered
2026-08-04
Start date
2026-08-20
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Diseases Associated with Staphylococcus lugdunensis

Interventions

case series:None

Sponsors

Guangdong Province Hospital for Women and Children Healthcare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who visited our hospital for the first time due to infection; 2.Within 2 weeks prior to the visit, the patients had not received any vaccination, undergone any open surgical procedures, or taken any antibiotics or immunosuppressive medications; 3.Within 2 weeks prior to the visit, the patients had not received any vaccination, undergone any open surgical procedures, or taken any antibiotics or immunosuppressive medications.

Exclusion criteria

Exclusion criteria: 1.Non-active infection: The organism is considered only colonization or contamination, with no documented records of treatment for active infection. 2.Mixed infection: Other definite pathogenic bacteria (e.g., Pseudomonas aeruginosa, Acinetobacter baumannii, fungi, etc.) were simultaneously isolated from the same site, and are clinically considered co-pathogens that may significantly interfere with the evaluation of outcomes for Staphylococcus lugdunensis infection. 3.Significant data deficiency: Critical clinical data or antimicrobial susceptibility test results are missing, rendering effective analysis impossible. 4.Repeated admissions: The same patient was repeatedly hospitalized for the same episode of infection; only the first visit record was included to avoid data duplication. 5.Treatment discontinuation or transfer: The patient was discharged against medical advice, discontinued treatment, or transferred to another hospital during the critical period of infection treatment, making outcome assessment indeterminate.

Design outcomes

Primary

MeasureTime frame
Genomic characterization and antimicrobial susceptibility profile of Staphylococcus lugdunensis in the local region;

Countries

China

Contacts

Public ContactGuo Junfei

Guangdong Province Hospital for Women and Children Healthcare

gjunfei@sina.com+86 20 39151542

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026